Pacylex Pharmaceuticals, Inc.
A new target in cancer care - triggering selective lethality with a new class of drugs.
9 employees · est. 2012 · Edmonton, Canada
Molecure is the larger of the two.
Side-by-Side Comparison
| Metric | Molecure | Pacylex Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2012 | 2012 |
| Headquarters | ||
| Headquarters | Warsaw, Poland | Edmonton, Canada |
| Employees | ||
| Employees | 85 larger | 9 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Secondary | Grant |
| Total Funding | ||
| Total Funding | $50.00M | $12.30M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Not tracked yet | Development of first-in-class NMT-inhibitor therapeutics, Clinical trials for zelenirstat, Partnership for ADC development |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer Patients, Pharmaceutical Companies, Clinical Researchers, Investors in Oncology |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Clinical Stage, Small Molecule Drug Discovery, Immunotherapy, Medicinal Chemistry, Respiratory Diseases, Inflammatory Diseases, Fibrotic Diseases, Chitinase Inhibitor, Arginase Inhibitor, Cancer Treatment, Phase I Clinical Trial, Phase II Clinical Trial, Public Research Partnerships, Listed On Stock Exchange | Cancer Therapy, Oncology, Clinical Stage Company, Small Molecule Drugs, Solid Tumors, Blood Cancers, Phase 1 Clinical Trial, Refractory Cancer, Combination Therapy, N-myristoylation Inhibitor, Drug Resistance, Bioavailability, MD Anderson, Phase 2 Study, AML |
| Website | ||
| Website | molecure.com | pacylex.com |
About Molecure
Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-cla...
About Pacylex Pharmaceuticals, Inc.
Pacylex Pharmaceuticals, Inc., founded in 2012 and headquartered in Canada, is a clinical-stage company at the forefront of cancer treatment innovation. With the slogan, "A new target in cancer care - triggering selective lethality with a new class of drugs," the company focuses on developing PCLX-0...
We will tell you when either one moves
BounceWatch watches Molecure and Pacylex Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Molecure and Pacylex Pharmaceutical... — by email.
Frequently Asked Questions
Compare Molecure with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Molecure on 12 Sep 2024, and Pacylex Pharmaceuticals, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.